Search

Author/Creator Shapiro, Amy

12. Real‐world data demonstrate improved bleed control and extended dosing intervals for patients with haemophilia B after switching to recombinant factor IX Fc fusion protein (rFIXFc) for up to 5 years. Issue 6 (4th October 2020)

Authors:
Shapiro, Amy; Chaudhury, Ateefa; Wang, Michael; Escobar, Miguel; Tsao, Elisa; Barnowski, Christopher; Feng, Jing; Jain, Nisha; Quon, Doris V.
Journal:
Haemophilia
Issue:
Volume 26:Issue 6(2020)
Page Start:
975
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

13. Real‐world data of immune tolerance induction using recombinant factor VIII Fc fusion protein in patients with severe haemophilia A with inhibitors at high risk for immune tolerance induction failure: A follow‐up retrospective analysis. Issue 1 (18th November 2020)

Authors:
Carcao, Manuel; Shapiro, Amy; Hwang, Nina; Pipe, Steven; Ahuja, Sanjay; Lieuw, Ken; Staber, Janice M.; Belletrutti, Mark; Sun, Haowei Linda; Ding, Hilda; Wang, Michael; Price, Victoria; Steele, MacGregor; Tsao, Elisa; Feng, Jing; Al‐Khateeb, Zahra; Dumont, Jennifer; Jain, Nisha
Journal:
Haemophilia
Issue:
Volume 27:Issue 1(2021)
Page Start:
19
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

17. Switching to recombinant factor IX Fc fusion protein prophylaxis results in fewer infusions, decreased factor IX consumption and lower bleeding rates. (11th September 2014)

Authors:
Powell, Jerry; Shapiro, Amy; Ragni, Margaret; Negrier, Claude; Windyga, Jerzy; Ozelo, Margareth; Pasi, John; Baker, Ross; Potts, James; Li, Shuanglian; Mei, Baisong; Pierce, Glenn F.; Robinson, Brian
Journal:
British journal of haematology
Issue:
Volume 168:Number 1(2015:Jan.)
Page Start:
113
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

18. The effect of emicizumab prophylaxis on long‐term, self‐reported physical health in persons with haemophilia A without factor VIII inhibitors in the HAVEN 3 and HAVEN 4 studies. Issue 5 (25th June 2021)

Authors:
Skinner, Mark W.; Négrier, Claude; Paz‐Priel, Ido; Chebon, Sammy; Jiménez‐Yuste, Victor; Callaghan, Michael U.; Lehle, Michaela; Niggli, Markus; Mahlangu, Johnny; Shapiro, Amy; Shima, Midori; Campinha‐Bacote, Avrita; Levy, Gallia G.; Oldenburg, Johannes; von Mackensen, Sylvia; Pipe, Steven W.
Journal:
Haemophilia
Issue:
Volume 27:Issue 5(2021)
Page Start:
854
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗